Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort.

Canchola AJ, Anton-Culver H, Bernstein L, Clarke CA, Henderson K, Ma H, Ursin G, Horn-Ross PL.

Cancer Causes Control. 2012 Jan 28. [Epub ahead of print]

2.

Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.

Suzuki R, Ye W, Rylander-Rudqvist T, Saji S, Colditz GA, Wolk A.

J Natl Cancer Inst. 2005 Nov 2;97(21):1601-8.

3.

Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort.

Canchola AJ, Chang ET, Bernstein L, Largent JA, Reynolds P, Deapen D, Ursin G, Horn-Ross PL.

Cancer Causes Control. 2010 Sep;21(9):1407-16. doi: 10.1007/s10552-010-9568-8. Epub 2010 Apr 30.

4.

Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.

Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR.

Arch Intern Med. 2006 Dec 11-25;166(22):2478-83.

PMID:
17159013
5.

Relative weight at age 12 and risk of postmenopausal breast cancer.

Bardia A, Vachon CM, Olson JE, Vierkant RA, Wang AH, Hartmann LC, Sellers TA, Cerhan JR.

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):374-8. doi: 10.1158/1055-9965.EPI-07-0389. Epub 2008 Feb 4.

6.

Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.

Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G, Horn-Ross PL, Largent J, Deapen DM, Lacey JV Jr, Bernstein L.

Breast Cancer Res. 2010;12(3):R35. doi: 10.1186/bcr2589. Epub 2010 Jun 18.

7.

Alcohol consumption and breast cancer risk among postmenopausal women following the cessation of hormone therapy use: the California Teachers Study.

Horn-Ross PL, Canchola AJ, Bernstein L, Clarke CA, Lacey JV Jr, Neuhausen SL, Reynolds P, Ursin G.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2006-13. doi: 10.1158/1055-9965.EPI-12-0418. Epub 2012 Jul 25.

8.
9.

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.

Fournier A, Fabre A, Mesrine S, Boutron-Ruault MC, Berrino F, Clavel-Chapelon F.

J Clin Oncol. 2008 Mar 10;26(8):1260-8. doi: 10.1200/JCO.2007.13.4338.

10.

Body size throughout adult life influences postmenopausal breast cancer risk among hispanic women: the breast cancer health disparities study.

John EM, Sangaramoorthy M, Hines LM, Stern MC, Baumgartner KB, Giuliano AR, Wolff RK, Slattery ML.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):128-37. doi: 10.1158/1055-9965.EPI-14-0560. Epub 2014 Oct 28.

11.

Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.

Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L.

Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):681-7.

12.

Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.

Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, Limburg PJ, Anderson KE, Cerhan JR.

Breast Cancer Res Treat. 2011 Feb;126(1):149-55. doi: 10.1007/s10549-010-1074-x. Epub 2010 Jul 29.

13.

Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.

Vrieling A, Buck K, Kaaks R, Chang-Claude J.

Breast Cancer Res Treat. 2010 Oct;123(3):641-9. doi: 10.1007/s10549-010-1116-4. Epub 2010 Aug 15. Review.

PMID:
20711809
14.

Risk factors for hormone receptor-defined breast cancer in postmenopausal women.

Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8.

15.

Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women.

Rosner B, Eliassen AH, Toriola AT, Hankinson SE, Willett WC, Natarajan L, Colditz GA.

Breast Cancer Res Treat. 2015 Apr;150(3):643-53. doi: 10.1007/s10549-015-3344-0. Epub 2015 Mar 22.

16.

Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.

Barnes BB, Steindorf K, Hein R, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol. 2011 Aug;35(4):345-52. doi: 10.1016/j.canep.2010.11.003. Epub 2010 Dec 14.

PMID:
21159569
17.

Overall and abdominal adiposity and premenopausal breast cancer risk among hispanic women: the breast cancer health disparities study.

John EM, Sangaramoorthy M, Hines LM, Stern MC, Baumgartner KB, Giuliano AR, Wolff RK, Slattery ML.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):138-47. doi: 10.1158/1055-9965.EPI-13-1007-T. Epub 2014 Oct 28.

18.
19.

Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study.

Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE.

Am J Epidemiol. 2009 May 15;169(10):1251-9. doi: 10.1093/aje/kwp036. Epub 2009 Mar 24.

20.

Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.

Fagherazzi G, Chabbert-Buffet N, Fabre A, Guillas G, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F.

Int J Obes (Lond). 2012 Mar;36(3):431-9. doi: 10.1038/ijo.2011.66. Epub 2011 Mar 22.

PMID:
21427693
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk